Clinical outcomes of hypomethylating agents and venetoclax in newly diagnosed unfit and relapsed/refractory paediatric, adolescent and young adult acute myeloid leukaemia patients.
Saved in:
| Title: | Clinical outcomes of hypomethylating agents and venetoclax in newly diagnosed unfit and relapsed/refractory paediatric, adolescent and young adult acute myeloid leukaemia patients. |
|---|---|
| Authors: | LeBlanc FR; Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Centre, Cincinnati, Ohio, USA., Breese EH; Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Centre, Cincinnati, Ohio, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., Burns KC; Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Centre, Cincinnati, Ohio, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., Chang EK; Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Centre, Cincinnati, Ohio, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., Jones LM; Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Centre, Cincinnati, Ohio, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., Lee L; Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Centre, Cincinnati, Ohio, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., Mizukawa B; Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Centre, Cincinnati, Ohio, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., Norris RE; Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Centre, Cincinnati, Ohio, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., O'Brien MM; Department of Pediatrics, University of Colorado, Aurora, Colorado, USA., Phillips CL; Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Centre, Cincinnati, Ohio, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., Perentesis JP; Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Centre, Cincinnati, Ohio, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., Rubinstein J; Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Centre, Cincinnati, Ohio, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., Pommert L; Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Centre, Cincinnati, Ohio, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA. |
| Source: | British journal of haematology [Br J Haematol] 2024 Sep; Vol. 205 (3), pp. 1055-1066. Date of Electronic Publication: 2024 Jul 31. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
